Pharmaceutical Executive January 17, 2024
Mike Hollan

As the technology becomes more ingrained within the Pharma industry’s processes, experts believe that regulation covering the use of AI is coming.

While the technology has been around for several years now, 2023 is the year the AI became a mainstream topic. For the general public, the conversation focused on generative AI, or programs that can generate responses, images, and videos based on user prompts. For the life sciences industry, however, the use of this technology goes beyond that.

In 2023, pharma companies fully embraced the used of AI, both in generative form and as highly complex data sorting algorithms. These programs were implemented across the spectrum of the industry, being included as part of the process from everything to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Govt Agencies, Regulations, Technology, Trends
Related Articles:
The case for human-centered AI
European Commission Approves Nvidia’s Proposed Acquisition of Run:ai
How Health Systems Can Collaborate on AI Tools
The Future Talent Equation: How To Identify And Retain Talent In The Age Of AI
A Roadmap For AI In Education: Turning Disruption Into Opportunity

Share This Article